2m 2m 2m 2m 2m 2m 2m
CNS PHARMA (CNSP)
NASDAQ
$5.11+$0.02 (+0.29%)
Price as of Jul 14, 2026 4:20 AM EDT- $7.5MMarket Cap
- -51.55%1-Year Change
- BiotechnologyIndustry
CNS PHARMA (CNSP)
$5.11+$0.02 (+0.29%)
CNSP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.09 | ||
Change | -$0.08 (-1.45%) | ||
Open | $4.99 | ||
High | $5.27 | ||
Low | $4.95 | ||
Previous Close | $5.17 | ||
Volume | 3,745 | ||
30-Day Average Volume | 12,102 | ||
1-Week Change | 2.21% | ||
1-Month Change | 4.09% | ||
1-Year Change | -51.55% | ||
3-Year Change | -99.99% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 1.5M | ||
Total Assets | $4.7M | ||
Market Cap | $7.5M | ||
Enterprise Value | $4.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$4.7M | ||
EBIT | $0.00 | ||
EBITDA | $1,868.00 | ||
Net Working Capital | -$504,148.00 | ||
EPS | -$7.30 | ||
Enterprise Value/EBITDA | 2,586 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 107 | ||
P/E | -1 | ||
PEG | N/A | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 07/22/2025 | ||
Earnings & Revenue